Demand for Ozempic and Wegovy is reaching new heights. Here’s why it can go even higher. | The motley fool
Ozempic and Wegovy. These are the two drugs that are the focus of any income or press release coming fromNovo Nordisk(NVO -0.09%). The Danish company struck gold not only with a cutting-edge diabetes drug in Ozempic, but also with an impressive weight loss treatment in Wegovy. Both drugs actually help people lose weight and are …
